Difference between revisions of "Education"

From QIBA Wiki
Jump to navigation Jump to search
 
(6 intermediate revisions by the same user not shown)
Line 13: Line 13:
 
If you do not already have an EndNote account: you can register for the free, web-based version called [https://access.clarivate.com/login?app=endnote '''EndNote Basic''']. If additional assistance is needed in gaining access to the collections please send an email to: [mailto:qiba@rsna.org?Subject=URL%20Encoded%20Subject&body=Body%20Text '''QIBA staff'''].
 
If you do not already have an EndNote account: you can register for the free, web-based version called [https://access.clarivate.com/login?app=endnote '''EndNote Basic''']. If additional assistance is needed in gaining access to the collections please send an email to: [mailto:qiba@rsna.org?Subject=URL%20Encoded%20Subject&body=Body%20Text '''QIBA staff'''].
  
==QIBA News==
+
 
 +
==U.S. Food and Drug Administration (FDA) Guidance==
 +
The Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket
 +
Submissions Guidance for Industry and Food and Drug Administration Staff was released on June 16, 2022, and can be accessed at this link or via the PDF below:
 +
 
 +
*https://www.fda.gov/regulatory-information/search-fda-guidance-documents/technical-performance-assessment-quantitative-imaging-radiological-device-premarket-submissions
 +
 
 +
This guidance document provides FDA's recommendations on the information, technical performance assessment, and user information that should be included in a premarket submission for radiological devices that include quantitative imaging functions. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of premarket submissions for radiological devices that include quantitative imaging functions.
 +
 
 +
*[[Media:06 16 2022 FDA Guidance.pdf | Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket ]] (June 16, 2022)
 +
 
 +
==QIBA Historical Initiative==
  
 
:[[Image:Cancer Moonshot.jpg|120px]]
 
:[[Image:Cancer Moonshot.jpg|120px]]
Line 21: Line 32:
 
*RSNA/QIBA is very pleased to announce that two of the QIBA Profiles relevant to cancer patients have been referenced and supported by the Federal Cancer Moonshot Initiative (https://medium.com/cancer-moonshot) as ways to advance research and outcomes.  
 
*RSNA/QIBA is very pleased to announce that two of the QIBA Profiles relevant to cancer patients have been referenced and supported by the Federal Cancer Moonshot Initiative (https://medium.com/cancer-moonshot) as ways to advance research and outcomes.  
 
*The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date.  Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.
 
*The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date.  Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.
 
  
 
==Biomarker Status Update Posters==
 
==Biomarker Status Update Posters==

Latest revision as of 15:13, 17 June 2022

QIBA in the Literature Citations

RSNA staff maintains a QIBA citation library in EndNote. Scientific journals featuring QIBA projects or articles that may reference QIBA and its efforts are included.

Articles are divided into three categories:

  • Generated by QIBA research teams
  • References QIBA
  • Metrology Publications

Instructions:

All QIBA leaders have been automatically provided access to the collections and anyone else will be given access upon request. If you already have an EndNote account: please log in to view the collections. All three QIBA citation groups should appear under, “Groups Shared by Others.”

If you do not already have an EndNote account: you can register for the free, web-based version called EndNote Basic. If additional assistance is needed in gaining access to the collections please send an email to: QIBA staff.


U.S. Food and Drug Administration (FDA) Guidance

The Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions Guidance for Industry and Food and Drug Administration Staff was released on June 16, 2022, and can be accessed at this link or via the PDF below:

This guidance document provides FDA's recommendations on the information, technical performance assessment, and user information that should be included in a premarket submission for radiological devices that include quantitative imaging functions. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of premarket submissions for radiological devices that include quantitative imaging functions.

QIBA Historical Initiative

Cancer Moonshot.jpg


Cancer Moonshot & QIBA [1]

  • RSNA/QIBA is very pleased to announce that two of the QIBA Profiles relevant to cancer patients have been referenced and supported by the Federal Cancer Moonshot Initiative (https://medium.com/cancer-moonshot) as ways to advance research and outcomes.
  • The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date. Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.

Biomarker Status Update Posters

QIBA Posters from RSNA Annual Meetings Archive


QIBA Special Interest Sessions at the RSNA Scientific Assembly and Annual Meeting

2018

2016


Presentations

2018

2017

2016

Google Chrome or Firefox browsers are recommended for viewing these PowerPoint presentations.

2015

2014

2010

2009

Consider also organizing or tagging presentations by topic?